New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ocugen, Inc.
OCGN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

204M

Biotechnology

Next Earning date - 31 Mar 2025

204M

Biotechnology

Next Earning date - 31 Mar 2025

0.70USD

Shape0.04 ( 6.47%)
Market Closed (as of Feb 13, 21:00 EDT)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-19%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated February 14, 2025
1W 0.39 % 1M -3.59 % 3M -25.13 % 1Y -5.80 %

Key Metrics

Shape
  • Market Cap

    204.45M


  • Shares Outstanding

    290.95M


  • Share in Float

    285.69M


  • Dividende

    0


  • Earning Date

    31 Mar 2025


  • Price Target

    0.7027


  • Average Volume

    4.68M


  • Beta

    3.766


  • Range

    0.64-2.105


  • Industry

    Biotechnology


  • Website

    https://www.ocugen.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

OCGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$40M

Shape3449%

2025-Revenue

$0.26

Shape-470%

2025-EPS

$8M

Shape36%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2024-10-15

Now: Buy

Cowen & Co.

initialise

Previous: Not converted

2023-03-01

Now: Outperform

Chardan Capital

downgrade

Previous: Not converted

2021-02-09

Now: Buy

H.C. Wainwright

upgrade

Previous: Not converted

2021-02-06

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.10
vs -0.07

Q1.23

arrow
arrow

N/A

-0.07
vs -0.09

Q2.23

arrow
arrow

N/A

-0.10
vs -0.09

Q3.23

arrow
arrow

N/A

-0.06
vs -0.10

Q4.23

arrow
arrow

N/A

-0.03
vs -0.10

Q1.24

arrow
arrow

N/A

-0.04
vs -0.07

Q2.24

arrow
arrow

N/A

-0.04
vs -0.10

Q3.24

arrow
arrow

N/A

-0.05
vs -0.06

Q4.24

arrow
arrow

N/A

-0.06
vs -0.03

Q1.25

arrow
arrow

N/A

-0.06
vs -0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

443K  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6M  vs NA

Q1.24

arrow
arrow

+129%

1M  vs 443K

Q2.24

arrow
arrow

NA

1.1M  vs NA

Q3.24

arrow
arrow

NA

1.1M  vs NA

Q4.24

arrow
arrow

-93%

400K  vs 6M

Q1.25

arrow
arrow

+12%

1.1M  vs 1M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-30%

-0.30
vs -0.22

Q1.23

arrow
arrow

-20%

-0.20
vs -0.30

Q2.23

arrow
arrow

-33%

-0.33
vs -0.20

Q3.23

arrow
arrow

-24%

-0.24
vs -0.33

Q4.23

arrow
arrow

-23%

-0.23
vs -0.24

Q1.24

arrow
arrow

-39%

-0.39
vs -0.23

Q2.24

arrow
arrow

-90%

-0.90
vs -0.39

Q3.24

arrow
arrow

-32%

-0.32
vs -0.90

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

107

107
vs 122

-12%

Q2.23

arrow
arrow

98

98
vs 107

-8%

Q3.23

arrow
arrow

82

82
vs 98

-16%

Q4.23

arrow
arrow

74

74
vs 82

-10%

Q1.24

arrow
arrow

89

89
vs 74

20%

Q2.24

arrow
arrow

107

107
vs 89

20%

Q3.24

arrow
arrow

123

123
vs 107

15%

Q4.24

arrow
arrow

46

46
vs 123

-63%

Earnings Growth

Latest News